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Objective: This study aimed to evaluate the structural beneﬁt of a new biomaterial composed of alginate-
chitosan (AC) beads dispersed in a hydrogel (H) derived from chitosan on the development of osteoar-
thritis (OA) in rabbit.
Design: OA was induced by the surgical transection of the anterior cruciate ligament in rabbits. Animals
received a single intra-articular injection (900 ml) of AC beads in H hydrogel, H hydrogel alone or saline a
week after surgery. OA development was followed by X-rays. Blood samples were collected throughout
the study to measure biological markers (Prostaglandins E2 e PGE2 and C reactive protein e CRP).
Macroscopic observation and histological evaluation of articular cartilage and synovial membrane were
performed 6 weeks after surgery.
Results: AC beads in H hydrogel prevented from the development of OA based on the reduction of the
Kellgren & Lawrence (K&L) score. It also signiﬁcantly reduced the histological score of cartilage lesion
severity. This effect was homogenous on every joint compartment. It was due to a signiﬁcant effect on
cartilage structure and cellularity scores. The injection of AC beads in H hydrogel also tended to reduce
the synovial membrane inﬂammation. No signiﬁcant variation of biological markers was noted.
Conclusions: The present pilot study provides interesting and promising results for the use of AC beads in
H hydrogel in animal. It indeed prevented the development of OA cartilage lesions without inﬂammatory
signs. The potencies of this biomaterial to protect OA joint should be further documented. It could then
represent a new alternative for viscosupplementation in human OA management.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a complex, multifactorial disease that af-
fects a whole organ, the joint1,2. This disease remains with no cure.
The principle of its treatment relies on the control of symptoms, i.e.,
inﬂammation and pain. Cartilage degeneration is one of the main
features that cause the loss of articular function in OA3. It is also
accompanied by the inﬂammation of synovial membrane and theY. Henrotin, Bone and Carti-
HU Sart-Tilman, 4000 Liège,
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s Research Society International. Psclerosis of subchondral bone. Based on the available therapeutics,
the main recommendations for the management of OA consist in
the combination of non-pharmacological and pharmacological
modalities in order to control OA symptoms4e8. In fact, the ideal
treatment for OA would not only control the symptoms but also
prevent, slow down or stop the degradation of the joint.
Viscosupplementation (VS) is a recommended intervention7,9,10
that proposes through an intra-articular injection to deal with OA
symptoms and to preserve the joint function. It is characterized by a
delayed onset of action and the prolonged duration of the symptom
relief. Indeed, the synovial ﬂuid protects the articular surface by
limiting the axial forces and reducing the friction between the
cartilage surfaces. It has elastic and viscous properties due to its
hyaluronic acid (HA) content. However, even if the synovial ﬂuid is
more abundant in OA, HA has an altered structure which leads to aublished by Elsevier Ltd. All rights reserved.
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jection of HA was for the past years, the VS of choice11. However,
one may consider VS with other compounds or biomaterials.
Depending on the used product, one may foresee the prevention
against cartilage degradation and/or the restoration of the articular
function.
VS has to be performed with a compound that has to be biocom-
patible with the cartilaginous tissue, weakly biodegradable, nontoxic
and not immunogenic. Natural compounds such as alginate12, chito-
san13 or collagen14 were shown to be suitable materials for cartilage
regeneration. Indeed their structure related to that of glycosamino-
glycans (GAGs)mimics thenatural environment in the cartilage extra-
cellular matrix and stimulates chondrogenesis in vitro15.
Chitosan is a linear natural polymer of D-glucosamine with a
variable frequency of N-acetyl-D-glucosamine units obtained by N-
deacetylation of chitin16 which is the most abundant natural
polymer after cellulose. It is present in the cell wall of fungi and the
exoskeleton of shellﬁshes and insects. Chitosan is an interesting
candidate for biomaterial that could be used for VS. Indeed, it has
relevant biological proprieties such as biocompatibility, progressive
degradability, absence of toxicity, lack of allergenicity and anti-
bacterial activity17. A chitosanehyaluronate hybrid gel was recently
proven to delay the progression of OA in rat meniscectomymodel18.
Moreover, in vitro studies have showed that chitosan promoted the
expression of cartilage matrix components by chondrocytes19,20
and reduced the production of inﬂammatory and catabolic medi-
ators21. These studies suggested that chitosan could be a good
biomaterial for cartilage tissue engineering. In addition, the mix
with alginate could provide the spherical shape to the biomaterial
and allow the homogenous distribution of chitosan in the matrix.
The aim of the present work was to evaluate the effect of a
unique intra-articular injection of a new biphasic biomaterial con-
sisting in amix of alginate-chitosan (AC) beads in a chitosan-derived
thermogelling (H) hydrogel on the cartilage lesion in a model of OA
in rabbit. One wonders if the injection could prevent from the
development of OA cartilage lesion. The effects of this new bioma-
terial were compared to the effects of H hydrogel alone and saline.
Method
Test products
To prepare AC beads, 1.33% (w/v) chitosan and 1.85% (w/v)
alginate solution were prepared separately by dissolving 1 g of
ultrapure medical-grade chitosan KiOmedine-CsU (kindly provided
by KitoZyme S.A.; Herstal, Belgium) in 75 mL 0.166 M acetic acid
and 1 g alginate (Pronova UP LVM; FMC BioPolymer AS, NovaMa-
trix, Sandvika, Norway) in 54.1 mL 0.123 M NaOH. The two solu-
tions were then mixed to obtain 0.5% (w/v) chitosan and 1.4% (w/v)
alginate solution. Chitosan was extracted from A. bisporus edible
mushrooms and characterized by a molecular weight of 42,000 Da
and 20.7 mol % of degree of acetylation. The pH, measured with
Microprocessor pH-mV Meter pH 526 (VWR, Leuven, Belgium) of
AC solution was 7.38  0.05. The beads were produced by a
vibrating nozzle device (Nisco Encapsulator Unit, Var D; Nisco En-
gineering Inc., Zurich, Switzerland) equipped with a syringe
(Perfusor Space, B. Braun Medical, Boulogne Billancourt, France)
pumping the solution through the nozzle. The vibration frequency
used to break up the liquid jet was set at 600 Hz and the nozzle
diameter was 200 mm. A stroboscopic lamp was set at the same
amplitude that the frequency used for the nozzle, in order to
visualize the falling droplets. The droplets fell into a 102 mM CaCl2
solution (SigmaeAldrich, Bornem, Belgium). After instantaneous
gelation the beads were incubated for 10 min in the CaCl2 solution
and washed with saline solution. The AC beads with a diameterbetween 600 and 900 mm were then mixed before intra-articular
injection in a thermogelling chitosan-derived (H) hydrogel which
was generously provided by KitoZyme SA. H hydrogel is composed
by ultrapure medical-grade chitosan KiOmedine-CsU which is
characterized by a molecular weight of 136,000 Da. At room tem-
perature, H hydrogel viscosity was 25 cP however at 37C, viscosity
increased to 1,000 cP (measured with a Brookﬁeld LVDV-II þ PRO
viscometer using a spindle 18 (Brookﬁeld Engineering Laboratories,
Middleboro, Massachusetts, USA)). The pH of H hydrogel was
7.48  0.03. The new biphasic biomaterial consisted in a homoge-
nously mix with a ratio of 1/1 of AC beads and H hydrogel.
Animals and treatment groups
OA was surgically induced by the transection of the anterior
cruciate ligament (ACLT) as previously described22 in 21 HYLA al-
bino rabbits (21 weeks, weighing 3.4  0.3 kg (mean  standard
deviation (SD)) at the time of surgery). Animals were randomly
divided into three groups after surgery: Group I (n ¼ 7): saline
(control); Group II (n ¼ 7): H hydrogel alone (H); and Group III
(n ¼ 7): AC beads in H hydrogel (AC þ H). The test compounds
(0.9 ml) were administered intra-articularly in the right operated
knee one week after surgery. Animals were euthanized 6 weeks
after surgery. All these interventions were performed by AGINKO
Research AG (Marly, Switzerland). This study was approved by the
Institutional Animal Care and Use Committee (IACUC) and the
Committee for Animal Protection of the Ministry of Industry and
Trade (106/2011).
Blood sampling and serum levels of biological markers
Blood samples were collected at AGINKO facilities from each
animal the day of surgery, the day of the injection and prior to
sacriﬁce. Serum was obtained from these samples and stored
at20C until analysis. Prostaglandins E2 (PGE2) weremeasured by
an ELISA detection kit according to the manufacturer’s recom-
mendations (DetectX Prostaglandin E2 High Sensitivity immuno-
assay; Arbor, Michigan, USA). Results were expressed in pg/ml. C
reactive protein (CRP) was measured by immunoturbidimetry ac-
cording to the manufacturer’s recommendations (DiAgam, Ghi-
slenghien, Belgium) using ARCHITECT (Abbott, Rungis, France).
Results were given in mg/ml.
X-rays
X-rays from the right knee were performed by AGINKO just
before surgery, at the time of injection and at sacriﬁce. Pictures
were acquired in extension. Theywere read by a radiologist blinded
to the treatment groups and scored according to the Kellgren and
Lawrence (K&L) scale. Brieﬂy, the score evaluate the presence of
osteophytes and the joint narrowing using a scale from 0 to 4,
where Grade 0 corresponded to no osteophytes; Grade 1, doubtful
osteophytes; Grade 2, minimal osteophytes, possibly with nar-
rowing, cysts and sclerosis; Grade 3, moderate or deﬁnite osteo-
phytes with moderate joint space narrowing; and Grade 4, severe
with large osteophytes and deﬁnite joint space narrowing.
Macroscopic evaluation
Right after sacriﬁce, the right knee was dissected and further
analyzed for its macroscopic appearance. To this aim, femoral
condyles and tibial plateaus were colored in India ink according to
the OARSI recommendations23. India ink uptake was scored using a
scale from 1 to 4, where Grade 1 corresponded to no uptake of India
ink, which indicated an intact surface; Grade 2, minimal focal
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evident large focal dark patches of ink uptake, which indicates
overt ﬁbrillation; and Grade 4, large general uptake of India Ink,
which indicates erosion of cartilage.
Histological evaluation of cartilage
Cartilage samples were processed for the histological evaluation
after the macroscopic evaluation. Femoral condyles and tibial pla-
teaus were ﬁxed in 10% neutral buffered formalin and further
embedded in parafﬁn after being decalciﬁed in DC2 medium
(Labonord, Templemars, France). Sections (5 mm) from the weight
bearing zones of the femoral condyles and tibial plateaus were
stained in Safranin-O/Fast green and toluidine blue. The lateral and
medial compartments were evaluated separately. The histological
evaluation of cartilage was done according to the OARSI recom-
mendations23. The severity of cartilage lesion was evaluated using
the scale provided by the latter mentioned guidelines. Brieﬂy, the
evaluation considered the staining of the cartilage matrix (0e6),
the structure of cartilage (0e11), the chondrocyte density (0e4)
and the cluster formation (0e3), where 0 represented a normal
situation. The maximum severity score was 24.
Histological evaluation of synovial membrane
Synovial membrane sampling was performed in the peri-
patellar region. Tissue samples were ﬁxed in 10% neutral buffered
formalin. Sections (5 mm) were stained in hematoxylin/eosin ac-
cording to a standard protocol. The histological evaluation of sy-
novial membrane was done according to the OARSI
recommendations23. The inﬂammation of synovial membrane was
evaluated using the scale provided by the latter mentioned
guidelines. Brieﬂy, the evaluation considered the synoviocyte pro-
liferation (0e3) and hypertrophy (0e3), the inﬂammatory inﬁltrate
considering the lymphoplasmacytic inﬁltrate (0e3) and aggregate/
follicle (0e2), the synovial stroma considering the villous hyper-
plasia (0e3), the proliferation of ﬁbroblast/ﬁbrocytes (0e3), the
proliferation of blood vessels (0e2), the presence of cartilage or
bone detritus (0e2) and hemosiderosis (0e2), where 0 represented
a normal situation. The maximum severity score was 24.
Statistical analysis
Data are given as mean (95% conﬁdence interval) in the text and
presented in box and whisker plot in the ﬁgures. Data were
considered independently for the purpose of statistical analysis.
They were analyzed and compared using a one-way ANOVATable I
Serum levels of biological markers, PGE2 and CRP throughout the study
Before ACLT surgery
PGE2 (pg/ml) Group I
Saline (control)
514 (288e741)
Group II
H
1,197 (491e1,902)
Group III
AC þ H
651 (65 to 1,367)
CRP (mg/ml) Group I
Saline (control)
5.7 (3.1 to 14.47)
Group II
H
5.8 (0.5 to 12.2)
Group III
AC þ H
2.2 (1.0e3.5)
Data are mean (95% conﬁdence interval). PGE2 and CRP were assayed as described in th
multiple comparison test. The analysis revealed no difference between groups. I.A.: intra
beads in H hydrogel.followed, if positive, by the Bonferroni multiple comparison post-
test. P-values were considered signiﬁcant when P < 0.05.
Results
Safety
Twenty-one rabbits were included in this study. One rabbit died
at the time of surgery when anesthesia was initiated. Thus, group II
was thereafter composed of six animals, whereas groups I and III
contained seven rabbits. All animals were subjected to a daily
physical examination during the study. Signs of toxicity, mortality,
abnormality, and food intake were monitored. No apparent sign of
toxicity were recorded.
Biological markers of inﬂammation
PGE2 and CRP were chosen to follow the inﬂammatory state of
animals throughout the study. The variation of their serum levels
are presented in Table I. PGE2 levels were increased one week after
surgery in the three groups. However, PGE2 tended to decrease after
injection of the test products or saline, when measured at the time
of sacriﬁce. CRP slightly increased after surgery in group I and II
while group III experienced a higher increase (Table I). At the time
of sacriﬁce, CRP level was decreased and returned to the level
measured before surgery in Group I (Control, saline), increased in
group II and remained stable in Group III in comparison with the
levels measured before injection of the test products. None of these
variations were statistically signiﬁcant.
X-rays
Standard radiographs were taken before and 6 weeks after the
ACLT surgery. Representative images from each treatment group are
illustrated on [Fig. 1(A)] and the individual score for each animal are
presented Table II. X-rays from each animal were graded indepen-
dently [Fig. 1(B)]. The X-ray score in the animals from Group III
(ACþ H) was signiﬁcantly less important than the one of the animals
treatedwithsaline (control) (1.5 (1.1e2.0)vs3.0 (1.1e4.0) respectively,
P ¼ 0.012), whereas the score of the animals treated with hydrogel
alone (Group II, H) exhibited an intermediate value (2.2 (0.9e3.4)).
However, the difference between groups I and II was not signiﬁcant.
Macroscopic observation
The macroscopic observation of the femoral condyles and tibial
plateaus revealed the presence of cartilage lesion in the weightBefore I.A. injection
(1 week after surgery)
At the time of sacriﬁce
(6 weeks after surgery)
1,268 (1,020e1,516) 1,032 (520e1,544)
3,476 (337e6,615) 2,211 (383e4,040)
1,528 (139e2,918) 1,293 (283e2,304)
6.7 (2.2e11.1) 5.1 (0.6 to 10.9)
6.8 (1.4e12.2) 12.7 (8.0 to 33.4)
14.4 (7.5e21.3) 15.4 (1.8 to 32.6)
e Method section. Data were analyzed with an ANOVA followed by the Bonferroni
-articular injection of the test products or saline; H: H hydrogel alone; AC þ H: AC
Fig. 1. (A) Representative X-rays from each treatment group (Group I: saline (control); Group II: H hydrogel alone (H); and Group III: AC beads in H hydrogel (AC þ H)) before the
ACLT surgery and before sacriﬁce (6 weeks after surgery); (B) X-ray grading according to the K&L scale. Data are presented as a box and whisker plot. Data were analyzed with an
ANOVA followed by the Bonferroni multiple comparison test. *P vs saline. N ¼ 7 for groups I and III, N ¼ 6 for group II.
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the India ink. The global observation of the samples from each
treatment group tended in favor of fewer lesions in the group III
(AC þ H) (2.0 (1.6e2.4)) in comparison to the other two groupsTable II
Individual values of the K&L score obtained for each animal 6 weeks after ACLT
surgery
Group I
Saline (control)
Group II
H
Group III
AC þ H
N ¼ 7 N ¼ 6 N ¼ 7
4 3 2
4 4 1
2 2 2
4 2 1
2 1 1
3 1 2
3 2(Group I, saline: 2.3 (1.9e2.8); Group II, H: 2.5 (2.0e3.0)). This
observation has been further investigated with the histological
analysis.Histological evaluation of cartilage lesions
The cartilage from femoral condyles and tibial plateaus was
evaluated. Representative sections are illustrated [Fig. 2(B)]. The
global score [Fig. 3(A)] that refers to all the compartments of the
knee joint (medial and lateral femoral condyles and tibial plateaus)
showed that Group III (AC þ H) had a cartilage of signiﬁcant better
quality. Indeed, the score for this group was signiﬁcantly less
important (11.0 (9.5e12.5); P< 0.001 vs I (saline) and P¼ 0.001 vs II
(H)) than the score of the two other groups (I (saline): 14.8 (13.5e
16.1); II (H): 14.4 (13.2e15.6)). The observation of the detailed score
for each evaluated parameter [Fig. 3(B)] highlighted the fact that
the signiﬁcant difference between the treatment groups came from
Fig. 2. (A) Macroscopic appearance of India ink colored femoral condyles and tibial plateaus from each treatment group; (B) Histologic sections showing the full thickness of
cartilage and subchondral bone in the weight bearing zone of the femoral condyles and tibial plateaus stained with Safranin-O/Fast green or Toluidine blue in each treatment group.
Group I: saline (control); Group II: H hydrogel alone (H); and Group III: AC beads in H hydrogel (AC þ H).
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larity. The effect on cellularity was not only due to the chondrocyte
density but also to the less abundance of clusters.
Finally, the analysis of the histological score considering the
different compartments separately (medial and lateral or femoral
condyles and tibial plateaus) revealed that the observed effect with
AC þ H in Group III was homogenous (Table III). No signiﬁcant
difference was observed between the different compartments with
the three treatments.
Histological evaluation of synovial inﬂammation
The synovial membrane was evaluated in the peri-patellar re-
gion. The histological score obtained for the three groups isillustrated Fig. 4. Mild synovitis was observed in the three groups.
The evaluation of Group I (Control, saline) revealed a total score of
11.0 (8.2e13.8) (maximal possible score 24). It was characterized by
the synovial lining hypertrophy and the presence of inﬂammatory
inﬁltrate. As shown on Fig. 4, both treatment groups tended to
decrease the synovial membrane histological score (Group II: 10.5
(7.0e14.0) and Group III: 9.5 (7.0e12.2)) even if the statistical sig-
niﬁcance was not reached.
Discussion
This study demonstrated the potential of a new biomaterial that
consisting in a mix of AC beads in chitosan-derived thermogelling
(H) hydrogel to protect against the development of cartilage lesion
Fig. 3. Cartilage histological score and comparison between treatment groups (Group I: saline (control); Group II: H hydrogel alone (H); and Group III: AC beads in H hydrogel
(AC þ H)). (A) Cartilage global score; (B) Detailed global score: values for the evaluated parameters. Data are presented as a box and whisker plot. Data were analyzed with an
ANOVA followed by the Bonferroni multiple comparison test. *P vs saline (control); #P vs H hydrogel alone (H). N ¼ 7 for groups I and III, N ¼ 6 for group II.
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ference between the injection of H hydrogel alone or with AC beads.
Indeed, X-rays indicated that the injection of AC beads in H
hydrogel prevented joint space narrowing and based on the his-
tological evaluation, the intra-articular injection of this new
biomaterial signiﬁcantly reduced the severity of cartilage lesion. In
addition, the intra-articular injection of AC beads in H hydrogel did
not produce any additional sign of inﬂammation. This difference
could be explained by the mechanical properties of the beads that
would be able to increase the viscosity of the hydrogel then
decreasing the friction coefﬁcient between joint surfaces and
absorbing strains applied on the joint during movement.
The ACLT rabbit model of OA as it was previously described22,24
was chosen for the present pilot study as it is a suitable model for
the evaluation of the structural effects of a therapy23. In addition, ithas been classically used to study the effects of different types of
intervention on OA, from physical intervention, to non-steroidal
anti-inﬂammatory drugs or new experimental therapeutics25e32.
The macroscopic observation of the different compartment of each
animal conﬁrmed that the ACLT surgery produced cartilage lesions
that were further quantiﬁed by the histological study. The cartilage
lesions observed in this study in the saline (control) group, 6 weeks
after the ACLT surgery, were moderate to severe. OA damages were
visible on the structure of cartilage (i.e., ﬁssure, pitting and cartilage
loss) as well as on the quality of the extra-cellular matrix and on
cellularity. The injection of AC beads in H hydrogel was able to
affect cartilage structure as well as cellularity, whereas H hydrogel
alone produced no effect. Of note, osteophytes were also observed
on the femoral condyles, tibial plateaus and trochlea but no dif-
ference was observed between the three groups (data not shown).
Table III
Total score as determined for the entire knee (global) and in the different
compartment of the knee
Group I
Saline (control)
Group II
H
Group III
AC þ H
N ¼ 7 N ¼ 6 N ¼ 7
Global 14.8 (13.5e16.1) 14.4 (13.2e15.6) 11.0 (9.5e12.5)
*P < 0.001
#P ¼ 0.001
Medial compartment 15.2 (13.5e17.0) 14.3 (12.2e16.3) 11.0 (8.2e13.8)
*P ¼ 0.016
Lateral compartment 14.3 (12.2e16.4) 14.6 (13.0e16.1) 10.9 (9.2e12.4)
*P ¼ 0.021
#P ¼ 0.018
Tibial plateaus 14.0 (12.4e15.6) 14.9 (13.3e16.5) 10.5 (8.6e12.5)
*P ¼ 0.013
#P ¼ 0.001
Femoral condyles 15.6 (13.4e17.7) 14.0 (12.0e16.0) 11.3 (8.9e13.7)
*P ¼ 0.017
Data are mean (95% conﬁdence interval). Data were analyzed with an ANOVA fol-
lowed, if positive, by the Bonferroni multiple comparison test. *P vs saline (control),
#P vs H.
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biomaterial for VS in OA for its potential structure-modifying effect.
However, one may keep in mind that the use of young animal could
yield to a better structure-modifying effect. In addition, one may
emphasize that no direct extrapolation from any kind of animal
model of OA can be done. So these results will have to be conﬁrmed
in human.
Surgery induced an inﬂammatory reaction as shown by the in-
crease of CRP and PGE2, two markers of inﬂammation33. No addi-
tional signs of inﬂammation were noted after the intra-articular
injection of the test products. Furthermore, the histologic evalua-
tion of the synovial membrane showed that the intra-articular in-
jection of AC beads in H hydrogel was associated with a decrease of
the synovial inﬂammation. Synovial inﬂammation is known to echo
the degenerative process and the disease progression23. The fact
that the intra-articular injection of AC beads in H hydrogel tended
to reduce the histological score of the synovial membrane could
mean that this treatment helped to contain the degenerative pro-
cess that occurs along OA development. This argument could be
sustained by the observations made with the cartilage histology on
the cellularity and the structure of cartilage. Indeed, AC beads in H
hydrogel improved cellularity and reduced the presence of clustersFig. 4. Synovial membrane histological score and comparison between treatment
groups (Group I: saline (control); Group II: H hydrogel alone (H); and Group III: AC
beads in H hydrogel (ACþ H)). Data are presented as a box and whisker plot. Data were
analyzed with an ANOVA followed by the Bonferroni multiple comparison test. The
analysis revealed no difference between groups. N ¼ 7 for groups I and III, N ¼ 6 for
group II.in cartilage. The development of clusters is a well-characterized
event of OA pathogenesis34. They are the results of an extensive
proliferation of chondrocytes that lead to chondrocyte hypertro-
phic differentiation and cell death34,35. Thus, the reduction of
cluster in OA cartilage due to the presence of AC beads in H
hydrogel could prevent from cartilage degradation and then pre-
serve its structure. Altogether these results are in favor of a
structure-modifying effect of AC beads in H hydrogel.
HA has beenwidely used for VS. It was described to alleviate OA
symptoms and even produce structural effect36,37. It was also
observed in rabbit in a meniscectomy model of OA38. Chitosan and
alginate could be candidates for VS. Alginate is required tomaintain
the spherical form of the biomaterials. As HA, chitosan is a natural
polysaccharide with a chemical structure close to that of GAGs.
They are also of non-animal origin. The results of the present work
showed that VS with the new biphasic biomaterial could protect
the articular cartilage from degradation.
VS has been employed in OA patients for many years. VS with HA
has been shown to delay the total knee replacement in OA patient39.
Onemay expect even better results with biomaterials that would be
better tolerated by patients. In addition, the AC beads in H hydrogel
could be used not only for VS in OA patients but also as drug delivery
system40,41 or cell carrier for transplantation42,43. The studied
biomaterial presents all the characteristics to fulﬁll the pre-requisites
for these two applications. Chitosan has already been proposed for
this kind of use42,44. These matters should be further investigated.
This study consisted in a ﬁrst proof of concept toward the
development of a new product for VS applied to the osteoarthritic
joint. It was performed in a small number of animal and with a
single formulation of the biomaterial. It aimed at ﬁrst testing the
potential of this new biomaterial. This research has to be further
pursued. Cartilage lesion in the ACLT rabbit model are usually
evaluated at 8 or 12 weeks23. The joint has been evaluated in the
present study, 6 weeks after surgery. Indeed, the choice was made
to evaluate the prophylactic effect of the intra-articular injection
performed 1 week after surgery on the development of the lesions
in early OA, since it was described in the ﬁrst 8 weeks of the
model45. Hence, the encouraging results that were obtained here
are in favor of the protective effect of this biomaterial, have to be
further described. The precise mechanism that leads to the
structure-modifying effect observed with the intra-articular injec-
tion of the biomaterial should be investigated. One may foresee a
mechanical effect through the beads themselves, since the injection
of hydrogel alone does not produce any signiﬁcant effect. Indeed,
these results are in the line of our previous observation in a pilot
experiment testing the mechanical properties of this biomaterial in
osteochondral defect in rabbit where AC beads resist to mechanical
stress generated by the animal locomotion (personal communica-
tion). Finally, as usually mentioned with VS, the remanence of the
test product has to be investigated.
Conclusion
The present pilot study provides interesting results supporting
the development of the new biphasic biomaterial, AC beads in
chitosan-derived thermogelling hydrogel for the intra-articular
treatment of OA in human. It indeed prevented the development
of OA cartilage lesions without additional inﬂammatory signs. The
potencies of this biomaterial to protect OA joint should be further
documented. It could then represent a new alternate for VS in
human OA management.
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